Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Pharmaceuticals & Biotech
Create a narrative
ImmunoPrecise Antibodies Community
NasdaqCM:IPA Community
1
Narratives
written by author
0
Comments
on narratives written by author
7
Fair Values set
on narratives written by author
Create a narrative
ImmunoPrecise Antibodies
Popular
Undervalued
Overvalued
Community Investing Ideas
ImmunoPrecise Antibodies
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
AI Driven Partnerships Will Open New Biotech Opportunities
Key Takeaways Strategic partnerships and tech collaborations are anticipated to boost revenue streams, improve net margins, and enhance operational efficiency. Relocation to Austin and a focus on AI-driven platforms aim to streamline operations, increase profitability, and access new growth opportunities.
View narrative
US$4.00
FV
88.8% undervalued
intrinsic discount
21.24%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
4 days ago
author updated this narrative
Your Valuation for
IPA
IPA
ImmunoPrecise Antibodies
Your Fair Value
US$
Current Price
US$0.45
28.7% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-47m
53m
2015
2018
2021
2024
2025
2027
2030
Revenue CA$53.2m
Earnings CA$6.5m
Advanced
Set Fair Value